To assess the efficiency of viral infection in DRG neurons, we used GFP/NeuN or tomato/NeuN double labelling to determine the percentage of AAV2/5 infected cells and showed that intrathecal injection of AAV2/5 produced a high infection rate (50 to 80%) in L3 to L5 DRG neurons (Fig. 5a). The gene discussed is RBFOX3; the disease is infection.